AI assistant
Sending…
PALISADE BIO, INC. — Director's Dealing 2019
Jun 27, 2019
35274_dirs_2019-06-27_7a3115d1-d574-4426-853c-9eb6d97d43e8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2019-06-17
Reporting Person: Mazzo David J (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Common Stock Purchase Option | $0.36 | 2029-06-17 | Common Stock (9091) | Direct |
Footnotes
F1: Compensatory grant for director services for the period from June 12, 2019 through June 30, 2019. The options vest fully on June 30, 2019.
More from PALISADE BIO, INC.
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 12
Annual Report
2026
Apr 29
Regulatory Filings
2026
Apr 2
Annual Report
2026
Mar 20
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 13
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2026
Feb 13
Director's Dealing
2026
Feb 11